Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes (EXPLORE)
This study has been completed.
First Posted: September 1, 2010
Last Update Posted: September 1, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Further study details as provided by Alexion Pharmaceuticals:
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
10 Years and older (Child, Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients at least 10 years of age with aplastic anemia, myelodyplastic syndromes or other bone marrow failure syndromes.
At least 10 years of age.
Has aplastic anemia, myelodysplastic syndromes or other bone marrow failure syndromes
Has any condition that might interfere with the patient's participation
Contacts and Locations
No Contacts or Locations Provided
Michael Bombara, Senior Director, Global Clinical Operations, Alexion Pharmaceuticals, Inc.